Clinical Trial Update: FIBERGRAFT Aeridyan Posterolateral Fusion Study [NA]

View source ↗

Summary

The document notes that the FIBERGRAFT Aeridyan Posterolateral Fusion Study is currently recruiting for degenerative spine disease, sponsored by DePuy Synthes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Degenerative Spine Disease

Snippet

Sponsor: DePuy Synthes Products, Inc. | Conditions: Degenerative Spine Disease | NA | Status: RECRUITING